<?xml version='1.0' encoding='utf-8'?>
<document id="23386702"><sentence text="Reversible inhibition of human carboxylesterases by acyl glucuronides."><entity charOffset="52-69" id="DDI-PubMed.23386702.s1.e0" text="acyl glucuronides" /></sentence><sentence text="Carboxylesterases hydrolyze esters, amides, and thioesters to produce carboxylic acids and resulting alcohols, amines, and thiols, respectively"><entity charOffset="36-42" id="DDI-PubMed.23386702.s2.e0" text="amides" /><entity charOffset="48-58" id="DDI-PubMed.23386702.s2.e1" text="thioesters" /><entity charOffset="70-86" id="DDI-PubMed.23386702.s2.e2" text="carboxylic acids" /><entity charOffset="101-109" id="DDI-PubMed.23386702.s2.e3" text="alcohols" /><entity charOffset="111-117" id="DDI-PubMed.23386702.s2.e4" text="amines" /><entity charOffset="123-129" id="DDI-PubMed.23386702.s2.e5" text="thiols" /><pair ddi="false" e1="DDI-PubMed.23386702.s2.e0" e2="DDI-PubMed.23386702.s2.e0" /><pair ddi="false" e1="DDI-PubMed.23386702.s2.e0" e2="DDI-PubMed.23386702.s2.e1" /><pair ddi="false" e1="DDI-PubMed.23386702.s2.e0" e2="DDI-PubMed.23386702.s2.e2" /><pair ddi="false" e1="DDI-PubMed.23386702.s2.e0" e2="DDI-PubMed.23386702.s2.e3" /><pair ddi="false" e1="DDI-PubMed.23386702.s2.e0" e2="DDI-PubMed.23386702.s2.e4" /><pair ddi="false" e1="DDI-PubMed.23386702.s2.e0" e2="DDI-PubMed.23386702.s2.e5" /><pair ddi="false" e1="DDI-PubMed.23386702.s2.e1" e2="DDI-PubMed.23386702.s2.e1" /><pair ddi="false" e1="DDI-PubMed.23386702.s2.e1" e2="DDI-PubMed.23386702.s2.e2" /><pair ddi="false" e1="DDI-PubMed.23386702.s2.e1" e2="DDI-PubMed.23386702.s2.e3" /><pair ddi="false" e1="DDI-PubMed.23386702.s2.e1" e2="DDI-PubMed.23386702.s2.e4" /><pair ddi="false" e1="DDI-PubMed.23386702.s2.e1" e2="DDI-PubMed.23386702.s2.e5" /><pair ddi="false" e1="DDI-PubMed.23386702.s2.e2" e2="DDI-PubMed.23386702.s2.e2" /><pair ddi="false" e1="DDI-PubMed.23386702.s2.e2" e2="DDI-PubMed.23386702.s2.e3" /><pair ddi="false" e1="DDI-PubMed.23386702.s2.e2" e2="DDI-PubMed.23386702.s2.e4" /><pair ddi="false" e1="DDI-PubMed.23386702.s2.e2" e2="DDI-PubMed.23386702.s2.e5" /><pair ddi="false" e1="DDI-PubMed.23386702.s2.e3" e2="DDI-PubMed.23386702.s2.e3" /><pair ddi="false" e1="DDI-PubMed.23386702.s2.e3" e2="DDI-PubMed.23386702.s2.e4" /><pair ddi="false" e1="DDI-PubMed.23386702.s2.e3" e2="DDI-PubMed.23386702.s2.e5" /><pair ddi="false" e1="DDI-PubMed.23386702.s2.e4" e2="DDI-PubMed.23386702.s2.e4" /><pair ddi="false" e1="DDI-PubMed.23386702.s2.e4" e2="DDI-PubMed.23386702.s2.e5" /></sentence><sentence text=" Uridine 5'-diphosphate- glucuronosyltransferases are colocalized with carboxylesterases and have the potential to further metabolize carboxylic acids to acyl glucuronides, but it is currently unknown if acyl glucuronides, being esters, also interact with carboxylesterases"><entity charOffset="134-150" id="DDI-PubMed.23386702.s3.e0" text="carboxylic acids" /><entity charOffset="154-171" id="DDI-PubMed.23386702.s3.e1" text="acyl glucuronides" /><entity charOffset="204-221" id="DDI-PubMed.23386702.s3.e2" text="acyl glucuronides" /><entity charOffset="229-235" id="DDI-PubMed.23386702.s3.e3" text="esters" /><pair ddi="false" e1="DDI-PubMed.23386702.s3.e0" e2="DDI-PubMed.23386702.s3.e0" /><pair ddi="false" e1="DDI-PubMed.23386702.s3.e0" e2="DDI-PubMed.23386702.s3.e1" /><pair ddi="false" e1="DDI-PubMed.23386702.s3.e0" e2="DDI-PubMed.23386702.s3.e2" /><pair ddi="false" e1="DDI-PubMed.23386702.s3.e0" e2="DDI-PubMed.23386702.s3.e3" /><pair ddi="false" e1="DDI-PubMed.23386702.s3.e1" e2="DDI-PubMed.23386702.s3.e1" /><pair ddi="false" e1="DDI-PubMed.23386702.s3.e1" e2="DDI-PubMed.23386702.s3.e2" /><pair ddi="false" e1="DDI-PubMed.23386702.s3.e1" e2="DDI-PubMed.23386702.s3.e3" /><pair ddi="false" e1="DDI-PubMed.23386702.s3.e2" e2="DDI-PubMed.23386702.s3.e2" /><pair ddi="false" e1="DDI-PubMed.23386702.s3.e2" e2="DDI-PubMed.23386702.s3.e3" /></sentence><sentence text="" /><sentence text="This study explores the ability of acyl glucuronides to act as substrates or inhibitors of human carboxylesterases 1 (hCES1) and 2 (hCES2)"><entity charOffset="35-52" id="DDI-PubMed.23386702.s5.e0" text="acyl glucuronides" /></sentence><sentence text="" /><sentence text="The stability of six acyl glucuronides in the presence of hCES1, hCES2, and buffer alone (100 mM potassium phosphate, pH 7"><entity charOffset="21-38" id="DDI-PubMed.23386702.s7.e0" text="acyl glucuronides" /><entity charOffset="97-116" id="DDI-PubMed.23386702.s7.e1" text="potassium phosphate" /><pair ddi="false" e1="DDI-PubMed.23386702.s7.e0" e2="DDI-PubMed.23386702.s7.e0" /><pair ddi="false" e1="DDI-PubMed.23386702.s7.e0" e2="DDI-PubMed.23386702.s7.e1" /></sentence><sentence text="4, 37°C) were investigated" /><sentence text=" Reversible inhibition of 4-nitrophenyl acetate hydrolysis by the acyl glucuronides was also studied"><entity charOffset="26-47" id="DDI-PubMed.23386702.s9.e0" text="4-nitrophenyl acetate" /><entity charOffset="66-83" id="DDI-PubMed.23386702.s9.e1" text="acyl glucuronides" /><pair ddi="false" e1="DDI-PubMed.23386702.s9.e0" e2="DDI-PubMed.23386702.s9.e0" /><pair ddi="false" e1="DDI-PubMed.23386702.s9.e0" e2="DDI-PubMed.23386702.s9.e1" /></sentence><sentence text=" Diclofenac-β-d-glucuronide was used to explore potential time-dependent inactivation"><entity charOffset="1-27" id="DDI-PubMed.23386702.s10.e0" text="Diclofenac-β-d-glucuronide" /></sentence><sentence text="" /><sentence text="The chemical stability half-life values for CGP 47292-β-d-glucuronide, diclofenac-β-d-glucuronide, (R)-naproxen-β-d-glucuronide, (S)-naproxen-β-d-glucuronide, ibuprofen-β-d-glucuronide (racemic), clopidogrel-β-d-glucuronide, and valproate-β-d-glucuronide were found to be 0"><entity charOffset="44-69" id="DDI-PubMed.23386702.s12.e0" text="CGP 47292-β-d-glucuronide" /><entity charOffset="71-97" id="DDI-PubMed.23386702.s12.e1" text="diclofenac-β-d-glucuronide" /><entity charOffset="99-127" id="DDI-PubMed.23386702.s12.e2" text="(R)-naproxen-β-d-glucuronide" /><entity charOffset="129-157" id="DDI-PubMed.23386702.s12.e3" text="(S)-naproxen-β-d-glucuronide" /><entity charOffset="159-184" id="DDI-PubMed.23386702.s12.e4" text="ibuprofen-β-d-glucuronide" /><entity charOffset="229-254" id="DDI-PubMed.23386702.s12.e5" text="valproate-β-d-glucuronide" /><pair ddi="false" e1="DDI-PubMed.23386702.s12.e0" e2="DDI-PubMed.23386702.s12.e0" /><pair ddi="false" e1="DDI-PubMed.23386702.s12.e0" e2="DDI-PubMed.23386702.s12.e1" /><pair ddi="false" e1="DDI-PubMed.23386702.s12.e0" e2="DDI-PubMed.23386702.s12.e2" /><pair ddi="false" e1="DDI-PubMed.23386702.s12.e0" e2="DDI-PubMed.23386702.s12.e3" /><pair ddi="false" e1="DDI-PubMed.23386702.s12.e0" e2="DDI-PubMed.23386702.s12.e4" /><pair ddi="false" e1="DDI-PubMed.23386702.s12.e0" e2="DDI-PubMed.23386702.s12.e5" /><pair ddi="false" e1="DDI-PubMed.23386702.s12.e1" e2="DDI-PubMed.23386702.s12.e1" /><pair ddi="false" e1="DDI-PubMed.23386702.s12.e1" e2="DDI-PubMed.23386702.s12.e2" /><pair ddi="false" e1="DDI-PubMed.23386702.s12.e1" e2="DDI-PubMed.23386702.s12.e3" /><pair ddi="false" e1="DDI-PubMed.23386702.s12.e1" e2="DDI-PubMed.23386702.s12.e4" /><pair ddi="false" e1="DDI-PubMed.23386702.s12.e1" e2="DDI-PubMed.23386702.s12.e5" /><pair ddi="false" e1="DDI-PubMed.23386702.s12.e2" e2="DDI-PubMed.23386702.s12.e2" /><pair ddi="false" e1="DDI-PubMed.23386702.s12.e2" e2="DDI-PubMed.23386702.s12.e3" /><pair ddi="false" e1="DDI-PubMed.23386702.s12.e2" e2="DDI-PubMed.23386702.s12.e4" /><pair ddi="false" e1="DDI-PubMed.23386702.s12.e2" e2="DDI-PubMed.23386702.s12.e5" /><pair ddi="false" e1="DDI-PubMed.23386702.s12.e3" e2="DDI-PubMed.23386702.s12.e3" /><pair ddi="false" e1="DDI-PubMed.23386702.s12.e3" e2="DDI-PubMed.23386702.s12.e4" /><pair ddi="false" e1="DDI-PubMed.23386702.s12.e3" e2="DDI-PubMed.23386702.s12.e5" /><pair ddi="false" e1="DDI-PubMed.23386702.s12.e4" e2="DDI-PubMed.23386702.s12.e4" /><pair ddi="false" e1="DDI-PubMed.23386702.s12.e4" e2="DDI-PubMed.23386702.s12.e5" /></sentence><sentence text="252, 0" /><sentence text="537, 0" /><sentence text="996, 1" /><sentence text="77, 3" /><sentence text="67, 5" /><sentence text="02, and 15" /><sentence text="2 hours, respectively" /><sentence text=" Diclofenac-β-d-glucuronide, clopidogrel-β-d-glucuronide, ibuprofen-β-d-glucuronide, (R)-naproxen-β-d-glucuronide, and (S)-naproxen-β-d-glucuronide selectively inhibited hCES1, with Ki values of 4"><entity charOffset="1-27" id="DDI-PubMed.23386702.s20.e0" text="Diclofenac-β-d-glucuronide" /><entity charOffset="29-56" id="DDI-PubMed.23386702.s20.e1" text="clopidogrel-β-d-glucuronide" /><entity charOffset="58-83" id="DDI-PubMed.23386702.s20.e2" text="ibuprofen-β-d-glucuronide" /><entity charOffset="85-113" id="DDI-PubMed.23386702.s20.e3" text="(R)-naproxen-β-d-glucuronide" /><entity charOffset="119-147" id="DDI-PubMed.23386702.s20.e4" text="(S)-naproxen-β-d-glucuronide" /><pair ddi="false" e1="DDI-PubMed.23386702.s20.e0" e2="DDI-PubMed.23386702.s20.e0" /><pair ddi="false" e1="DDI-PubMed.23386702.s20.e0" e2="DDI-PubMed.23386702.s20.e1" /><pair ddi="false" e1="DDI-PubMed.23386702.s20.e0" e2="DDI-PubMed.23386702.s20.e2" /><pair ddi="false" e1="DDI-PubMed.23386702.s20.e0" e2="DDI-PubMed.23386702.s20.e3" /><pair ddi="false" e1="DDI-PubMed.23386702.s20.e0" e2="DDI-PubMed.23386702.s20.e4" /><pair ddi="false" e1="DDI-PubMed.23386702.s20.e1" e2="DDI-PubMed.23386702.s20.e1" /><pair ddi="false" e1="DDI-PubMed.23386702.s20.e1" e2="DDI-PubMed.23386702.s20.e2" /><pair ddi="false" e1="DDI-PubMed.23386702.s20.e1" e2="DDI-PubMed.23386702.s20.e3" /><pair ddi="false" e1="DDI-PubMed.23386702.s20.e1" e2="DDI-PubMed.23386702.s20.e4" /><pair ddi="false" e1="DDI-PubMed.23386702.s20.e2" e2="DDI-PubMed.23386702.s20.e2" /><pair ddi="false" e1="DDI-PubMed.23386702.s20.e2" e2="DDI-PubMed.23386702.s20.e3" /><pair ddi="false" e1="DDI-PubMed.23386702.s20.e2" e2="DDI-PubMed.23386702.s20.e4" /><pair ddi="false" e1="DDI-PubMed.23386702.s20.e3" e2="DDI-PubMed.23386702.s20.e3" /><pair ddi="false" e1="DDI-PubMed.23386702.s20.e3" e2="DDI-PubMed.23386702.s20.e4" /></sentence><sentence text="32 ± 0" /><sentence text="47, 24" /><sentence text="8 ± 4" /><sentence text="2, 355 ± 38, 468 ± 21, 707 ± 64 µM, respectively, but did not significantly inhibit hCES2" /><sentence text=" Valproate-β-d-glucuronide and CGP 47292-β-d-glucuronide did not inhibit either hCES"><entity charOffset="1-26" id="DDI-PubMed.23386702.s25.e0" text="Valproate-β-d-glucuronide" /><entity charOffset="31-56" id="DDI-PubMed.23386702.s25.e1" text="CGP 47292-β-d-glucuronide" /><pair ddi="false" e1="DDI-PubMed.23386702.s25.e0" e2="DDI-PubMed.23386702.s25.e0" /><pair ddi="false" e1="DDI-PubMed.23386702.s25.e0" e2="DDI-PubMed.23386702.s25.e1" /></sentence><sentence text=" Time-dependent inactivation of hCES1 by diclofenac-β-d-glucuronide was not observed"><entity charOffset="41-67" id="DDI-PubMed.23386702.s26.e0" text="diclofenac-β-d-glucuronide" /></sentence><sentence text=" Lastly, both hCES1 and hCES2 were shown not to catalyze the hydrolysis of the acyl glucuronides studied"><entity charOffset="79-96" id="DDI-PubMed.23386702.s27.e0" text="acyl glucuronides" /></sentence><sentence text="" /><sentence text="Drug-drug interaction studies may be warranted for drugs that metabolize to acyl glucuronides due to the potential inhibition of hCESs"><entity charOffset="76-93" id="DDI-PubMed.23386702.s29.e0" text="acyl glucuronides" /></sentence><sentence text="" /></document>